Researchers at New York City-based Mount Sinai Health System have identified distinct biological markers in patients with mild Crohn’s disease, potentially paving the way for more personalized and ...

A new study led by researchers at Mount Sinai Health System has identified distinct biological signatures in patients with ...

A low-emulsifier-containing diet led to a threefold increased likelihood of improvement in symptoms of Crohn’s disease ...

Guselkumab shows significant clinical and endoscopic benefits for adults with moderate to severe Crohn disease, offering a promising treatment alternative.

I think the most important thing when you think about differentiating patients with ulcerative colitis from Crohn’s disease is that ulcerative colitis, by definition, starts in the rectum and ...

A breakdown of Crohn’s disease, its symptoms, causes, and long-term impact on health. Explore the causes, symptoms, diagnosis, and complications.

Guselkumab is the first and only interleukin-23 inhibitor that offers both subcutaneous and intravenous induction options for moderately to severely active Crohn’s disease.

New treatments for Crohn's disease being studied The University of New Mexico Hospital also specializes in Crohn's care for children.

Living with Crohn’s disease While Crohn’s disease presents significant challenges, modern medical advances have greatly improved the outlook for people with this condition.

People with Crohn's disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, with the bacterium Mediterraneibacter gnavus being a ...

Crohn’s disease, a debilitating inflammatory bowel disease, has many known contributing factors, including bacterial changes in the microbiome that foster an inflammatory environment.

Eyssimont writes special essay for NHL.com about his experience with Crohn's disease Lightning center discusses dealing with disease, stigma that comes with it ...